Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-012226
Filing Date
2025-05-23
Accepted
2025-05-23 14:31:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9104
  Complete submission text file 0001641172-25-012226.txt   10922
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Subject) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94246 | Film No.: 25981355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 14179 LAUREL TRAIL WELLINGTON FL 33414
Business Address 14179 LAUREL TRAIL WELLINGTON FL 33414 561-793-7233
GSB Holdings, Inc. (Filed by) CIK: 0001893130 (see all company filings)

EIN.: 510313750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G